STAT+: China moves to restrict foreign biotech acquisitions
摘要
STAT+ 报道，中国正采取措施限制外国对本国生物科技企业的收购。该报道为 STAT+ 订阅专享内容，正文未公开具体限制措施与实施范围。同期生物科技动态还包括 Isomorphic 的 AI 布局进展与加州 84 亿美元科研资助计划。
摘要由模型根据原文撰写，以原文为准。
正文 · 原文
Waiting on Isomorphic’s AI ambition, California’s $8.4 billion research measure, and more biotech news
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
I might have been just as unblinking as Elizabeth during the three hours of “You Can See Everything.” Seats-edge viewing experience. What did you think?
Also: We’ll be in Madrid later this week for the European Society for Medical Oncology’s annual meeting, and we’ll be penning an ESMO in 30 Seconds newsletter. Sign up here.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Biotech Correspondent
Meghana Keshavan covers biotech and contributes to The Readout newsletter.
注意转载授权 · 阅读原文
来源：STAT News · statnews.com
引用原文
Meghana Keshavan. STAT+: China moves to restrict foreign biotech acquisitions[EB/OL]. (2026-10-19)[访问日期]. https://www.statnews.com/2026/10/19/biotech-news-china-moves-to-restrict-foreign-biotech-acquisitons/?utm_campaign=rss.